“A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis” (2010) Al Mustansiriyah Journal of Pharmaceutical Sciences, 7(1), pp. 90–105. doi:10.32947/ajps.v7i1.321.